FLAC Frazier Lifesciences Acquisition Corporation Class A

Frazier Lifesciences Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was founded in 2020 and is based in Seattle, Washington.

$9.87  +0.18 (1.82%)
As of 11/22/2022 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  02/08/2021
Outstanding shares:  14,301,000
Average volume:  13,488
Market cap:   $141,150,870
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%